EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Preventing Weight Regain After Glucagon‐Like Peptide‑1 Therapy Discontinuation: A Pilot Randomized Controlled Trial

Kelseanna Hollis-Hansen iD, Alexander Vonderschmidt iD, Carolyn Haskins iD, Ryan M Kane iD, Jaime P Almandoz iD, Ildiko Lingvay iD

Obesity Science & Practice · 2026-10 · 12 (5)

DOI: 10.1002/osp4.70194 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Obesity Science & Practice, online erschienen am 07.10.2026. Verfasst von Kelseanna Hollis-Hansen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Food is Medicine Institute Tufts University Friedman School of Nutrition Science and Policy Boston Massachusetts USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are effective treatments for obesity, but discontinuation is common due to cost, insurance coverage limitations, side effects, patient preference, and other factors. Weight regain often occurs rapidly after cessation, yet few evidence‐based strategies exist to support weight maintenance during this transition. This pilot randomized trial examined whether a digital wellness application or medically tailored meals (MTM) could mitigate weight gain during the first 4 months after GLP‐1 cessation.

Methods

In this pilot randomized trial, adults with prior GLP‐1‐induced weight loss were randomized to usual care, wellness application, or MTM at the time of GLP‐1 cessation. Surveys assessed adherence and satisfaction (primary outcome) as well as exploratory outcomes, diet quality, and perceived health. Weight (exploratory) was measured monthly using validated Bluetooth scales.

Results

Participants ( n = 39) were randomized to control ( N = 14), digital wellness application ( N = 12), or MTM ( N = 13) and had a mean baseline BMI 31.4 (SD 6.3) kg/m 2 . Diet quality, perceived health, adherence, and satisfaction did not significantly differ by group, though some estimates suggested possible trends favoring the wellness application. Relative to control, both the wellness application and MTM groups had less total weight gain: Wellness application −7.16% (95% CI: −12.27, −2.04) and MTM −7.17% (−12.20, −2.14).

Conclusions

These findings suggest that structured support may attenuate early weight gain after GLP‐1 cessation. Larger, more diverse trials with longer follow‐up and clinical outcomes are needed to confirm results and clarify mechanisms.

Autor:innen und Institutionen

  • Food is Medicine Institute Tufts University Friedman School of Nutrition Science and Policy Boston Massachusetts USA.
  • Peter O'Donnell Jr. School of Public Health UT Southwestern Medical Center Dallas Texas USA.
  • Division of General Internal Medicine, Department of Medicine Tufts University School of Medicine Tufts University Boston Massachusetts USA.
  • Division of Endocrinology, Department of Internal Medicine UT Southwestern Medical Center Dallas Texas USA.

ORCID-Profile: Kelseanna Hollis-Hansen, Alexander Vonderschmidt, Carolyn Haskins, Ryan M Kane, Jaime P Almandoz, Ildiko Lingvay

Förderung

  • NIDDK NIH HHS
  • National Institutes of Health

Zitieren

APA

Hollis-Hansen, K., Vonderschmidt, A., Haskins, C., Kane, R. M., Almandoz, J. P., & Lingvay, I. (2026). Preventing Weight Regain After Glucagon‐Like Peptide‑1 Therapy Discontinuation: A Pilot Randomized Controlled Trial. Obesity Science & Practice, 12(5). https://doi.org/10.1002/osp4.70194

Vancouver

Hollis-Hansen K, Vonderschmidt A, Haskins C, Kane RM, Almandoz JP, Lingvay I. Preventing Weight Regain After Glucagon‐Like Peptide‑1 Therapy Discontinuation: A Pilot Randomized Controlled Trial. Obesity Science & Practice. 2026;12(5). doi:10.1002/osp4.70194

BibTeX
@article{HollisHansen2026,
  author = {Hollis-Hansen, Kelseanna and Vonderschmidt, Alexander and Haskins, Carolyn and Kane, Ryan M and Almandoz, Jaime P and Lingvay, Ildiko},
  title = {Preventing Weight Regain After Glucagon‐Like Peptide‑1 Therapy Discontinuation: A Pilot Randomized Controlled Trial},
  journal = {Obesity Science & Practice},
  year = {2026},
  volume = {12},
  number = {5},
  doi = {10.1002/osp4.70194}
}
Kostenlos starten →